Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel
- 1 April 1985
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 31 (4), 395-408
- https://doi.org/10.1016/0010-7824(85)90006-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Changes in serum apo-lipoprotein AI and sex-hormone-binding globul in levels after treatment with two different progestins administered alone and in combination with ethinyl estradiolContraception, 1984
- Androgenic Action of Progestins and Possible Synandrogenic Properties of Antiandrogens Used in Oral ContraceptivesGynecologic and Obstetric Investigation, 1984
- A metabolic assessment of different oral contraceptivesJournal of Obstetrics and Gynaecology, 1983
- Results of a study to determine the effects of three oral contraceptives on serum lipoprotein levelsFertility and Sterility, 1982
- A randomized study of metabolic effects of four low-estrogen oral contraceptives: I. Results after 6 cyclesContraception, 1981
- Lipoprotein Changes May Be Minimized by Proper Composition of a Combined Oral ContraceptiveFertility and Sterility, 1981
- Binding of a contraceptive progestogen Org 2969 and its metabolites to receptor proteins and human sex hormone binding globulinThe Journal of Steroid Biochemistry and Molecular Biology, 1981
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.BMJ, 1980
- A new enzymatic method for determination of serum choline-containing phospholipidsClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASEThe Lancet, 1975